AC:PSEAyala Corp. Analysis

Accenture’s stock is trading well below its 20‑day (≈$173) and 50‑day (≈$178) simple moving averages, with the price at $127.98 and a deep‑oversold RSI around 21, indicating short‑term weakness. The MACD is bearish, showing the line below the signal and a negative histogram, while volume is rising, suggesting that a further test of the $125 support level could be imminent.
Fundamentally, the company appears markedly undervalued: a discounted cash‑flow fair value of roughly $372 versus the current price implies over 180% upside, and the trailing P/E of ~10 is far below the industry average of ~38. Revenue is growing at 8% YoY, margins are solid, free cash flow exceeds $12 billion, and the dividend yield of 3.9% is supported by a modest 51% payout ratio and strong balance‑sheet metrics. Low beta (~0.57) and a diversified global footprint temper the high 30‑day volatility (~74%), positioning Accenture as a fundamentally sound, dividend‑sustainable investment despite near‑term price pressure.